Skip to content

To study the effect of lasuna churna and shatpushpa ghana vati in PCOS

EFFECT OF LASHUNA CHURNA AND SHATAPUSHPA GHANA VATI IN PCOS - AN OPEN LABEL RANDOMIZED COMPARATIVE CLINICAL STUDY - Nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072804
Enrollment
40
Registered
2024-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr Anjum Maheboobpasha Mujawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects with signs and symptoms of PCOS. 2) Subjects aged between 18- 40 years.

Exclusion criteria

Exclusion criteria: 1) Subjects already on another drug treatment for PCOS like (OC Pills) 2) Subjects with other functional and structural pathology of reproductive organs. 3) Subjects with known cases of systemic disorders like renal disorders, and metabolic disorders like thyroid dysfunction and gastritis.

Design outcomes

Primary

MeasureTime frame
Regularity of cycle and reduction in acneTimepoint: 5 months

Secondary

MeasureTime frame
Reduction in hirsutism and Acanthosis nigricansTimepoint: 5 months

Countries

India

Contacts

Public ContactDr Anjum Maheboobpasha Mujawar

JSS Ayurveda Medical College and Hospital

vidya.dr@gmail.com9980760076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026